{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:02:43Z","timestamp":1761516163583,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.4158\/ep14097.cr","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T21:59:07Z","timestamp":1407880747000},"page":"207-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Destructive Thyroiditis Followed by Hypothyroidism Associated with Infliximab Therapy"],"prefix":"10.1016","volume":"20","author":[{"given":"Cigdem","family":"Ozkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev Eroglu","family":"Altinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethem Turgay","family":"Cerit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Muhittin","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusun Balos","family":"Toruner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujde","family":"Akturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuri","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.4158\/EP14097.CR_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2133.2012.11208.x","article-title":"Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data","volume":"167","author":"Rustin","year":"2012","journal-title":"Br J Dermatol."},{"issue":"Suppl 1","key":"10.4158\/EP14097.CR_bb0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1478-6354-13-S1-S2","article-title":"Infliximab: 12 years of experience","volume":"13","author":"Smolen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.4158\/EP14097.CR_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/imt.13.10","article-title":"Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature","volume":"5","author":"Jain","year":"2013","journal-title":"Immunotherapy."},{"key":"10.4158\/EP14097.CR_bb0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3899\/jrheum.100968","article-title":"Vasculitis, vitiligo, thyroiditis, and altered hormone levels after anti-tumor necrosis factor therapy","volume":"38","author":"Lahita","year":"2011","journal-title":"J Rheumatol."},{"key":"10.4158\/EP14097.CR_bb0025","doi-asserted-by":"crossref","first-page":"216939","DOI":"10.1155\/2013\/216939","article-title":"Infliximab-Induced Hypothyroidism: A Novel Case and Postulations concerning the Mechanism","volume":"2013","author":"Cerniglia","year":"2013","journal-title":"Case Rep Med."},{"key":"10.4158\/EP14097.CR_bb0030","series-title":"Werner & Ingbar\u2019s Thyroid","first-page":"525","article-title":"Chronic autoimmune thyroiditis","author":"Weetman","year":"2013"},{"key":"10.4158\/EP14097.CR_bb0035","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","article-title":"Thyroiditis","volume":"348","author":"Pearce","year":"2003","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14097.CR_bb0040","first-page":"1769","article-title":"Thyroiditis","volume":"73","author":"Bindra","year":"2006","journal-title":"Am Fam Physician."},{"key":"10.4158\/EP14097.CR_bb0045","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/thy.2010.1635","article-title":"Drugs affecting thyroid function","volume":"20","author":"Barbesino","year":"2010","journal-title":"Thyroid."},{"key":"10.4158\/EP14097.CR_bb0050","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/jnci\/djr373","article-title":"Thyroid dysfunction from antineoplastic agents","volume":"103","author":"Hamnvik","year":"2011","journal-title":"J Natl Cancer Inst."},{"key":"10.4158\/EP14097.CR_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/jc.2013-2201","article-title":"Alemtuzumabrelated thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis","volume":"99","author":"Daniels","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP14097.CR_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.crohns.2010.12.007","article-title":"Autoimmune hepatitis during infliximab therapy for Crohn\u2019s disease: a case report","volume":"5","author":"Doyle","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.4158\/EP14097.CR_bb0065","first-page":"217","article-title":"New-onset vitiligo during long-term, stable infliximab treatment of pityriasis rubra pilaris","volume":"12","author":"Mattox","year":"2013","journal-title":"J Drugs Dermatol."},{"key":"10.4158\/EP14097.CR_bb0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00296-008-0684-7","article-title":"Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis","volume":"29","author":"Bodur","year":"2009","journal-title":"Rheumatol Int."},{"key":"10.4158\/EP14097.CR_bb0075","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/BF03347788","article-title":"Prevalence of anti-thyroid peroxidase antibodies in autoimmune and nonautoimmune thyroid disorders in a relatively low-iodine environment","volume":"17","author":"Knobel","year":"1994","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP14097.CR_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00296-004-0542-1","article-title":"Anti- TNFalpha therapy in rheumatoid arthritis and autoimmunity","volume":"26","author":"Caramaschi","year":"2006","journal-title":"Rheumatol Int."},{"key":"10.4158\/EP14097.CR_bb0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.crohns.2010.05.011","article-title":"Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists","volume":"4","author":"Chowers","year":"2010","journal-title":"J Crohns Colitis."},{"key":"10.4158\/EP14097.CR_bb0090","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.crohns.2013.01.001","article-title":"Infliximab induces a dysregulated tissuehoming profile on human T-lymphocytes in-vitro: a novel mechanism for paradoxical inflammation?","volume":"7","author":"Peake","year":"2013","journal-title":"J Crohns Colitis."},{"key":"10.4158\/EP14097.CR_bb0095","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20072707","article-title":"Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells","volume":"205","author":"Notley","year":"2008","journal-title":"J Exp Med."},{"key":"10.4158\/EP14097.CR_bb0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.2008.08732.x","article-title":"Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: metaanalysis of randomized controlled trials","volume":"159","author":"Schmitt","year":"2008","journal-title":"Br J Dermatol."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20419226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20419226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/X23606762G167753.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:58:13Z","timestamp":1761515893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20419226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1530891X20419226"],"URL":"https:\/\/doi.org\/10.4158\/ep14097.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Destructive Thyroiditis Followed by Hypothyroidism Associated with Infliximab Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14097.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}